Strikingly, in vivo silencing of KV3.4 was able to reduce glial fibrillary acidic protein (GFAP) over-expression and Aβ1-42 trimer burden in the Tg2576 mice brain, a transgenic model of AD [32]. This evidence concerns the gene GFAP and Alzheimer disease.